The EGFR exon 19 variant, which was not detected by ODxTT‐M, was confirmed to be L747P by the Oncomine Comprehensive Assay v3 (OCA v3; Thermo Fisher Scientific), which was performed as part of a lung cancer genomic screening project for individualized medicine in Japan (LC‐SCRUM) (UMIN ID: UMIN000010234). The gene discussed is EGFR; the disease is lung carcinoma.